Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON49143Active, not recruiting
Open-label, single-arm trial of midazolam in Not applicable, sponsored by QPS. Primary endpoints: Population pharmacokinetic-pharmacodynamic model development, Pharmacokinetic model parameters and 2 more. Started Mar 2020; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON49143.